Insider trade

Officer sold ~$1.82M of IDXX shares in the open market

Traded Feb 10, 2026 · Filed Feb 11, 2026

~$1.82M
Reported value · 2,809 sh @ $649.2599: 9,863
Holds after · shares reported: -19.9%
stock since the trade · S&P 500 +10.4%, $646.53 → $517.75 on Oct 1

Why it stands out

Idexx Laboratories's Executive Vice President sold $1.82M of Idexx Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 10, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 11, 2026

Officer$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,823,771

Shares × reported transaction price

Timing vs results

8 days after results of Feb 2, 2026, 84 days before results of May 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $646.53 on Feb 10, 2026, 79% above its 52-week low and 16% below its high, after a 6% drop over the previous 30 trading days

52-week range $361.04 (Apr 8, 2025) to $766.68 (Nov 25, 2025), 70% of the way up, from 251 adjusted closes. 30 trading days earlier: $688.48 on Dec 26, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+2.2%	+0.5%	+1.7%
30 days	-5.0%	-1.8%	-3.2%
90 days	-14.3%	+9.0%	-23.3%
180 days	-5.0%	+13.1%	-18.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0000874716-26-000005
Filed / recorded: Feb 11, 2026, 10:01 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: IDEXX LABORATORIES INC /DE
Issuer CIK: 874716
Ticker: IDXX
Reporting person: George Fennell
Relationship: Officer
Officer title: Executive Vice President
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 10, 2026
Transaction code: S
Shares / units: 2,809
Price per share: $649.2599
Acquired / disposed: Disposed (D)
Shares owned after: 9,863
Ownership form: Direct
Amendment: No

Footnotes from the filing

Represents the weighted average price of the shares sold ranging from a low of $649.05 to a high of $649.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Around the same time

7mo ago

197Shares · @ $505.53

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

7mo ago

197Derivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold7mo ago

~$1.12MReported value · 1,758 sh @ $634.5718

Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.

Why it stands out Official record